Gossamer Bio advances the Feb. 2026 PROSERA Phase 3 readout for seralutinib in PAH, with expanded endpoints and a new ILD trial. Learn why GOSS stock is a hold.

BIO-Europe Startup Spotlight returns to Lisbon in March 2026, showcasing Europe’s top early-stage biotech pitches to industry leaders.

A comprehensive analysis of the overall social and political changes in North Korea following the development of underground ...

It's been an eventful year for the Chicago Bears. We're listing the top 15 moments of the year for the franchise.

The Laurel Denise Planner features a monthly calendar, four to five weekly short pages (so you can plan anywhere from 28 to ...

I am Chevy Chase and You're Not is a celebrity documentary that is all set to release on January 1, 2026, on CNN.

Riot Games, best known for titles like Valorant and League of Legends and the Vanguard anti-cheat software, has often been ...

The successor to our pick for the best overall hiking boot, 2025’s X Ultra 5 improves on its predecessor in some key ways, ...

The mean of analysts' price targets for Theravance Bio (TBPH) points to a 42.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among ...

This week, books examined the state of our planet and included a biography of Michael Lynch and a wintry retelling of an Irish legend.